| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.006 |
| mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.006 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.007 |
| mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.007 |
| mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.007 |
| mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.009 |
| mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
| mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.01 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |